InflaRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
CEONiels Christoph Riedemann
CEONiels Christoph Riedemann
Employees74
Employees74
HeadquartersJena, Thueringen
HeadquartersJena, Thueringen
Founded2007
Founded2007
Employees74
Employees74
IFRX Key Statistics
Market cap58.40M
Market cap58.40M
Price-Earnings ratio-0.83
Price-Earnings ratio-0.83
Dividend yield—
Dividend yield—
Average volume545.88K
Average volume545.88K
High today$0.88
High today$0.88
Low today$0.8311
Low today$0.8311
Open price$0.85
Open price$0.85
Volume177.36K
Volume177.36K
52 Week high$2.82
52 Week high$2.82
52 Week low$0.7113
52 Week low$0.7113
IFRX News
TipRanks 4d
InflaRx Receives Nasdaq Deficiency Notice for Share PriceElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own IFRX. This list is generated using Robinhood data, and it’s not a recommendation.